Back to results
US 11,529,382 B2Granted
Lactobacillus fermentum strain V3 and its efficacies of intestinal microflora regulation, anti-inflammation and cancer prevention
AssigneeSyngen Biotech Co., Ltd.
InventorsWei-Jen Chen, Shiuan-Huei Wu, Chiau-Ling Gung, Yu-Lun Tsai
Life of this patent
Estimating the term…
Abstract
The present invention provides a novel Lactobacillus fermentum strain, named Lactobacillus fermentum strain V3, and its use in manufacturing a pharmaceutical composition or a food composition for regulating intestinal microflora and treating and/or preventing an inflammatory diseases and/or a cancer.
Claims5
A composition in a form of a pharmaceutical composition or a food composition, comprising
- heat-inactivated Lactobacillus fermentum strain V3 (the strain V3) that is a biological pure culture of Lactobacillus fermentum strain V3 (the strain V3) deposited at Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH, Germany with deposit number DSM33166 on May 28, 2019, and at least one of a pharmaceutically acceptable carrier, a pharmaceutically acceptable excipient, or a suitable drinkable liquid.
Dependencies are inferred from the claim text.